Tanguler Tolga's Insider Trades & SAST Disclosures
Tanguler Tolga's most recent trade in Alnylam Pharmaceuticals Inc was a trade of 14,137 Common Stock done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Tanguler Tolga.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 14,137 | 28,482 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 7,819 | 7,819 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 243.36 per share. | 03 Mar 2025 | 142 | 28,209 (0%) | 0% | 243.4 | 34,557 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 242.37 per share. | 03 Mar 2025 | 131 | 28,351 (0%) | 0% | 242.4 | 31,750 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 244.41 per share. | 03 Mar 2025 | 96 | 28,113 (0%) | 0% | 244.4 | 23,463 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 245.26 per share. | 03 Mar 2025 | 70 | 28,043 (0%) | 0% | 245.3 | 17,168 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 246.17 per share. | 03 Mar 2025 | 29 | 28,014 (0%) | 0% | 246.2 | 7,139 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 247.33 per share. | 03 Mar 2025 | 3 | 28,011 (0%) | 0% | 247.3 | 742 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,667 | 1,666 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,667 | 14,858 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 242.44 per share. | 27 Feb 2025 | 192 | 14,461 (0%) | 0% | 242.4 | 46,548 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 241.51 per share. | 27 Feb 2025 | 82 | 14,653 (0%) | 0% | 241.5 | 19,804 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 243.23 per share. | 27 Feb 2025 | 78 | 14,383 (0%) | 0% | 243.2 | 18,972 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 240.32 per share. | 27 Feb 2025 | 50 | 14,735 (0%) | 0% | 240.3 | 12,016 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 244.11 per share. | 27 Feb 2025 | 38 | 14,345 (0%) | 0% | 244.1 | 9,276 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 236.50 per share. | 27 Feb 2025 | 28 | 14,830 (0%) | 0% | 236.5 | 6,622 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 239.17 per share. | 27 Feb 2025 | 23 | 14,785 (0%) | 0% | 239.2 | 5,501 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 238.32 per share. | 27 Feb 2025 | 22 | 14,808 (0%) | 0% | 238.3 | 5,243 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 3,000 | 14,660 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 251.42 per share. | 25 Nov 2024 | 826 | 13,275 (0%) | 0% | 251.4 | 207,673 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 250.68 per share. | 25 Nov 2024 | 318 | 14,101 (0%) | 0% | 250.7 | 79,716 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 249.60 per share. | 25 Nov 2024 | 215 | 14,419 (0%) | 0% | 249.6 | 53,664 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 252.27 per share. | 25 Nov 2024 | 84 | 13,191 (0%) | 0% | 252.3 | 21,191 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 247.77 per share. | 25 Nov 2024 | 26 | 14,634 (0%) | 0% | 247.8 | 6,442 | Common Stock |
| Lexeo Therapeutics Inc. | Tolga Tanguler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 3,278 | 13,265 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 229.93 per share. | 24 Jun 2024 | 304 | 12,442 (0%) | 0% | 229.9 | 69,899 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 229.06 per share. | 24 Jun 2024 | 266 | 12,746 (0%) | 0% | 229.1 | 60,930 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 232.54 per share. | 24 Jun 2024 | 216 | 12,127 (0%) | 0% | 232.5 | 50,229 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 234.66 per share. | 24 Jun 2024 | 185 | 11,827 (0%) | 0% | 234.7 | 43,412 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 235.19 per share. | 24 Jun 2024 | 167 | 11,660 (0%) | 0% | 235.2 | 39,277 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 228.30 per share. | 24 Jun 2024 | 129 | 13,012 (0%) | 0% | 228.3 | 29,451 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 233.53 per share. | 24 Jun 2024 | 115 | 12,012 (0%) | 0% | 233.5 | 26,856 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 231.59 per share. | 24 Jun 2024 | 99 | 12,343 (0%) | 0% | 231.6 | 22,927 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 221.71 per share. | 24 Jun 2024 | 59 | 13,206 (0%) | 0% | 221.7 | 13,081 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 226.82 per share. | 24 Jun 2024 | 34 | 13,141 (0%) | 0% | 226.8 | 7,712 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 225.56 per share. | 24 Jun 2024 | 18 | 13,175 (0%) | 0% | 225.6 | 4,060 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 224.15 per share. | 24 Jun 2024 | 13 | 13,193 (0%) | 0% | 224.2 | 2,914 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,279 | 9,279 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 4,751 | 9,987 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 1,667 | 5,737 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 1,667 | 3,333 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 154.54 per share. | 27 Feb 2024 | 216 | 5,521 (0%) | 0% | 154.5 | 33,381 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 155.45 per share. | 27 Feb 2024 | 170 | 5,351 (0%) | 0% | 155.5 | 26,427 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 156.38 per share. | 27 Feb 2024 | 100 | 5,251 (0%) | 0% | 156.4 | 15,638 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 157.29 per share. | 27 Feb 2024 | 14 | 5,237 (0%) | 0% | 157.3 | 2,202 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tanguler Tolga | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 158.00 per share. | 27 Feb 2024 | 1 | 5,236 (0%) | 0% | 158 | 158 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 3,278 | 5,079 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 148.24 per share. | 15 Feb 2024 | 519 | 4,191 (0%) | 0% | 148.2 | 76,937 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 147.50 per share. | 15 Feb 2024 | 369 | 4,710 (0%) | 0% | 147.5 | 54,428 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 149.03 per share. | 15 Feb 2024 | 121 | 4,070 (0%) | 0% | 149.0 | 18,033 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 3,277 | 3,277 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 194.94 per share. | 26 Apr 2023 | 625 | 1,968 (0%) | 0% | 194.9 | 121,838 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 193.93 per share. | 26 Apr 2023 | 562 | 2,593 (0%) | 0% | 193.9 | 108,989 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 193.18 per share. | 26 Apr 2023 | 122 | 3,155 (0%) | 0% | 193.2 | 23,568 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 197.08 per share. | 26 Apr 2023 | 103 | 1,801 (0%) | 0% | 197.1 | 20,299 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 195.66 per share. | 26 Apr 2023 | 64 | 1,904 (0%) | 0% | 195.7 | 12,522 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 10,352 | 10,352 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 5,025 | 5,025 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 5,025 | 0 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 232.53 per share. | 01 Feb 2023 | 1,293 | 953 (0%) | 0% | 232.5 | 300,661 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 225.80 per share. | 01 Feb 2023 | 963 | 3,989 (0%) | 0% | 225.8 | 217,445 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 233.31 per share. | 01 Feb 2023 | 953 | 0 (0%) | 0% | 233.3 | 222,344 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 231.35 per share. | 01 Feb 2023 | 865 | 2,246 (0%) | 0% | 231.4 | 200,118 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 226.62 per share. | 01 Feb 2023 | 561 | 3,428 (0%) | 0% | 226.6 | 127,134 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 230.20 per share. | 01 Feb 2023 | 185 | 3,111 (0%) | 0% | 230.2 | 42,587 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 227.68 per share. | 01 Feb 2023 | 128 | 3,296 (0%) | 0% | 227.7 | 29,143 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 223.97 per share. | 01 Feb 2023 | 73 | 4,952 (0%) | 0% | 224.0 | 16,350 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 227.50 per share. | 01 Feb 2023 | 4 | 3,424 (0%) | 0% | 227.5 | 910 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2022 | 3,629 | 5,383 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 03 Aug 2022 | 1,754 | 3,629 (0%) | 0% | 210 | 368,340 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 189.76 per share. | 03 Aug 2022 | 1,618 | 2,011 (0%) | 0% | 189.8 | 307,032 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 218.71 per share. | 03 Aug 2022 | 541 | 313 (0%) | 0% | 218.7 | 118,322 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 217.61 per share. | 03 Aug 2022 | 440 | 854 (0%) | 0% | 217.6 | 95,748 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 216.21 per share. | 03 Aug 2022 | 398 | 1,294 (0%) | 0% | 216.2 | 86,052 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.50 per share. | 03 Aug 2022 | 170 | 1,841 (0%) | 0% | 210.5 | 35,785 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 215.03 per share. | 03 Aug 2022 | 149 | 1,692 (0%) | 0% | 215.0 | 32,039 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 220.95 per share. | 03 Aug 2022 | 105 | 109 (0%) | 0% | 221.0 | 23,200 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 225.15 per share. | 03 Aug 2022 | 104 | 0 (0%) | 0% | 225.2 | 23,416 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 219.53 per share. | 03 Aug 2022 | 99 | 214 (0%) | 0% | 219.5 | 21,733 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 224.00 per share. | 03 Aug 2022 | 5 | 104 (0%) | 0% | 224 | 1,120 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 05 Jul 2022 | 1,754 | 1,754 (0%) | 0% | 150 | 263,100 | Common Stock |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 5,026 | 5,025 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 5,026 | 5,026 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Tolga Tanguler | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.67 per share. | 01 Feb 2022 | 1,518 | 3,508 (0%) | 0% | 144.7 | 219,609 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges